P
Philip C. Calder
Researcher at University of Southampton
Publications - 808
Citations - 70822
Philip C. Calder is an academic researcher from University of Southampton. The author has contributed to research in topics: Polyunsaturated fatty acid & Eicosapentaenoic acid. The author has an hindex of 125, co-authored 747 publications receiving 59110 citations. Previous affiliations of Philip C. Calder include Southampton General Hospital & Radboud University Nijmegen Medical Centre.
Papers
More filters
Book ChapterDOI
Modifying the gut microbiome through diet: effects on the immune system of elderly subjects
TL;DR: There is good evidence that probiotics can improve in vivo and ex vivo measures of immune function in older adults, and further research is required before conclusions can be made regarding the role that prebiotics or synbiotics may have on immunefunction in the elderly.
Journal ArticleDOI
Normative Data for Handgrip Strength in Saudi Older Adults Visiting Primary Health Care Centers.
Saad M. Bindawas,Vishal Vennu,Saada M. Al-Orf,Sulaiman A. Al-Shammari,Maysoon M. Al-Amoud,Philip C. Calder,May N. Al-Muammar,Adel A. Alhamdan +7 more
TL;DR: The current study presents specific norms for HGS in Saudi older adults by age, sex, and hand and examines the utility of these norms for prediction of morbidity and mortality in this population.
Journal ArticleDOI
Polyunsaturated fatty acids and inflammation
TL;DR: The n-6 polyunsaturated fatty acid, arachidonic acid, is a precursor of prostaglandins, leukotrienes and related compounds that have important roles as mediators and regulators of inflammation.
Journal ArticleDOI
Efficacy of Docosahexaenoic Acid for the Prevention of Necrotizing Enterocolitis in Preterm Infants: A Randomized Clinical Trial.
Mariela Bernabe-García,Philip C. Calder,Raúl Villegas-Silva,Maricela Rodríguez-Cruz,Luis Chávez-Sánchez,Leonardo Cruz-Reynoso,Leovigildo Mateos-Sánchez,Gabriel Lara-Flores,Augusto R Aguilera-Joaquín,Luisa Sánchez-García +9 more
TL;DR: A randomized double-blind parallel-group (1:1) trial was carried out in two neonatal intensive care units of two tertiary hospitals as discussed by the authors, where two hundred and twenty-five preterm newborns with an expected functional gastrointestinal tract were recruited and received an enteral dose of 75 mg of docosahexaenoic acid (DHA)/kg body weight or high-oleic sunflower oil daily for 14 days from the first enteral feed after birth.